Deep Bio

At a glance

Pricing

Enterprise.

HIPAA

Not disclosed

SOC 2

Not disclosed

EHRs

—

Founded

—

HQ

KR

Bottom line

CE-marked Gleason grading + prostate AI, Korean leader.

Free tier available.

Overview

Pricing

What it costs

Free tier only; no paid plans publicly disclosed.

Source: vendor pricing page. Verified May 23, 2026.

Peer-reviewed coverage

What the literature says

3 peer-reviewed studies indexed on PubMed evaluate Deep Bio in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.

External validation of an artificial intelligence model for Gleason grading of prostate cancer on prostatectomy specimens.

Schmidt B, Soerensen SJC, Bhambhvani HP, et al.· BJU Int· 2025Observational

To externally validate the performance of the DeepDx Prostate artificial intelligence (AI) algorithm (Deep Bio Inc., Seoul, South Korea) for Gleason grading on whole-mount prostate histopathology, considering potential variations observed when applying AI models trained on biopsy samples to radical prostatectomy (RP) specimens due to inherent differences in tissue representation and sample size. The commercially available DeepDx Prostate AI algorithm is an automated Gleason grading system that was previously trained using 1133 prostate core biopsy images and validated on 700 biopsy images fro…

Acoustic Resolution Photoacoustic Microscopy Imaging Enhancement: Integration of Group Sparsity with Deep Denoiser Prior.

Zhang Z, Pan Z, Lin Z, et al.· IEEE Trans Image Process· 2025

Acoustic resolution photoacoustic microscopy (AR-PAM) is a novel medical imaging modality, which can be used for both structural and functional imaging in deep bio-tissue. However, the imaging resolution is degraded and structural details are lost since its dependency on acoustic focusing, which significantly constrains its scope of applications in medical and clinical scenarios. To address the above issue, model-based approaches incorporating traditional analytical prior terms have been employed, making it challenging to capture finer details of anatomical bio-structures. In this paper, we p…

Somatic Symptoms of Depression Lose Association with Mortality upon Adjustment for Frailty: Analysis from the Fitness Haemodialysis Cohort.

Anderson BM, Qasim M, Correa G, et al.· Int J Nephrol· 2023

The somatic symptom component of depression is associated with increased hospitalisation and mortality and poorer health-related quality of life (HRQOL). However, the relationship of subsets of depression symptoms with frailty and outcomes is not known. This study aimed to (1) explore the relationship between the Clinical Frailty Scale (CFS) and components of depression and (2) their association with mortality, hospitalisation, and HRQOL in haemodialysis recipients. We conducted a prospective cohort study of prevalent haemodialysis recipients, with deep bio-clinical phenotyping including CFS…

See all on PubMed